The alteration of microrna expression profiles in cutaneous malignant melanoma and benign melanocytic nevi
- 作者: Tsyrenzhapova S.V.1, Belonogov R.N.1, Sergeeva E.Y.1,2, Ruksha T.G.1
-
隶属关系:
- Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
- Siberian federal university
- 期: 卷 19, 编号 4 (2021)
- 页面: 27-33
- 栏目: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113443
- DOI: https://doi.org/10.29296/24999490-2021-04-05
- ID: 113443
如何引用文章
详细
全文:
作者简介
Seseg Tsyrenzhapova
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: tsyrenzhapovasv.krasgmu@gmail.com
assistant of the Department of pathological physiology.
Roman Belonogov
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: ro-x@yandex.ru.o
associated professor of the Department of pathological physiology.
Ekaterina Sergeeva
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Siberian federal university
Email: e.yu.sergeeva@mail.ru
professor of the Department of pathological physiology.
Tatyana Ruksha
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: tatyana_ruksha@mail.ru
Head of the Department of pathological physiology.
参考
- Aksenenko M., Palkina N., Komina A., Tashireva L., Ruksha T. Differences in microRNA expression between melanoma and healthy adjacent skin. BMC Dermatol. 2019; 19 (1): 1. https://doi.org/10.1186/s12895-018-0081-1
- Ge X., Niture S., Lin M., Cagle P., Li P.A., Kumar D. MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8. Sci. Rep. 2021; 11 (1): 5660. https://doi.org/10.1038/s41598-021-85097-6
- Davis L.E., Shalin S.C., Tackett A.J. Current state of melanoma diagnosis and treatment. Cancer Biol. Ther. 2019; 20 (11): 1366-79. https://doi.org/10.1080/15384047.2019.1640032
- Lu T.X., Rothenberg M.E. MicroRNA. J. Allergy Clin. Immunol. 2018; 141 (4): 1202-7. https://doi.org/10.10Wj.jaci.2017.08.034
- Li Y., Kowdley K.V. MicroRNAs in common human diseases. Genomics proteomics bioinformatics. 2012; 10 (5): 246-53. https://doi.org/10.1016/j.gpb.2012.07.005
- Motti M.L., Minopoli M., Di Carluccio G., Ascierto P.A., Carriero M.V. MicroRNAs as key players in melanoma cell resistance to MAPK and immune checkpoint inhibitors. Int. J. Mol. Sci. 2020; 21 (12): 4544. https://doi.org/10.3390/ijms21124544
- Thyagarajan A., Tsai K.Y., Sahu R.P. MicroRNA heterogeneity in melanoma progression. Semin. Cancer Biol. 2019; 59: 208-20. https://doi.org/10.10Wj.semcancer.2019.05.021
- Long Y., Tao H., Karachi A., Grippin A.J., Jin L., Chang Y.E., Zhang W., Dyson K.A., Hou A.Y., Na M., Deleyrolle L.P., Sayour E.J., Rahman M., Mitchell D.A., Lin Z., Huang J. Dysregulation of glutamate transport enhances Treg function that promotes VEGF blockade resistance in glioblastoma. Cancer Res. 2020; 80 (3): 499-509. https://doi.org/10.1158/0008-5472.CAN-19-1577
- Dupin E., Le Douarin N.M. Development of melanocyte precursors from the vertebrate neural crest. Oncogene. 2003; 22 (20): 3016-23. https://doi.org/10.1038/sj.onc.1206460
- Yang X., Du W.W., Li H., Liu F., Khorshidi A., Rutnam Z.J., Yang B.B. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 2013; 41 (21): 9688-704. https://doi.org/10.1093/nar/gkt680
- Shan S.W., Fang L., Shatseva T., Rutnam Z.J., Yang X., Du W., Lu W.Y., Xuan J.W., Deng Z., Yang B.B. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J. Cell Sci. 2013; 126 (6): 1517-30. https://doi.org/10.1242/jcs.122895
- Chen L., Huang K., Yi K., Huang Y., Tian X., Kang C. Premature microRNA-based therapeutic: a «one-two punch» against cancers. Cancers (Basel). 2020; 12 (12): 3831. https://doi.org/10.3390/cancers12123831
- Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. USA. 2008; 105 (5): 1608-13. https://doi.org/10.1073/pnas.0707594105
- Serrano-Gomez S.J., Maziveyi M., Alahari S.K. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol. Cancer, 2016; 15: 18. https://doi.org/10.1186/s12943-016-0502-x
- Gonzalez-Ruiz L., Gonzalez-Moles M.A., Gonzalez-Ruiz I., Ruiz-Avila I., Ayen A., Ramos-Garcia P. An update on the implications of cyclin D1 in melanomas. Pigment Cell Melanoma Res. 2020; 33 (6): 788-805. https://doi.org/10.1111/pcmr.12874
- Valiulyte I., Steponaitis G., Kardonaite D., Tamasauskas A., Kazlauskas A. A SEMA3 signaling pathway-based multi-biomarker for prediction of glioma patient survival. Int. J. Mol. Sci. 2020; 21 (19): 7396. https://doi.org/10.3390/ijms21197396
- Gabrovska P.N., Smith R.A., Tiang T., Weinstein S.R., Haupt L.M., Griffiths L.R. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gene. 2011; 489 (2): 63-9. https://doi.org/10.1016/j.gene.2011.08.024
- Tian TV, Tomavo N., Huot L., Flourens A., Bonnelye E., Flajollet S., Hot D., Leroy X., de Launoit Y., Duterque-Coquillaud M. Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2. Oncogene. 2014,33 (17): 2204-14. https://doi.org/10.1038/onc.2013.176
- Xiao M., Li J., Li W., Wang Y., Wu F., Xi Y., Zhang L., Ding C., Luo H., Li Y., Peng L., Zhao L., Peng S., Xiao Y., Dong S., Cao J., Yu W. MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol. 2017; 14 (10): 1326-34. https://doi.org/10.1080/15476286.2015.1112487
- Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007; 318 (5858): 1931-4. https://doi.org/10.1126/science.1149460